+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera



Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera



Research in Virology 144(6): 471-478



The present study was aimed at comparing specificities and cross-reactivities of immune mouse sera obtained from mice infected with a low (2 times 10-2 or 20 immunological infectious focus units (if u) or high (2 times 10-6 ifu) dose of various strains of lymphocytic choriomeningitis virus (LCMV). Neutralization titres of the various antisera were determined by an infectious focus reduction assay. This assay was performed on MC57G and on Vero E6 cells using the commonly utilized laboratory strains of LCMV WE, Docile, Armstrong, Armstrong Clone 13, Pasteur, Traub and Aggressive. Experiments with immune sera revealed broad cross-neutralization, demonstrating a variable but close serological relationship between the various strains of LCMV.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008155805

Download citation: RISBibTeXText

PMID: 8140290

DOI: 10.1016/s0923-2516(06)80062-2


Related references

An improved method for determining neutralizing antibody against lymphocytic choriomeningitis virus in human sera. Journal of General Virology 41(2): 377-383, 1978

A new method to detect lymphocytic choriomeningitis virus-specific antibody in human sera. Journal of General Virology 37(1): 85-92, 1977

The effect of storage on the neutralizing capacity of sera for the virus of lymphocytic choriomeningitis. Zentralblatt für Bakteriologie 185: 343-354, 1962

A study of human sera antibodies capable of neutralizing the virus of lymphocytic choriomeningitis. Publ Health Repts 54(22): 938-944, 1939

Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors. Journal of Virology 81(12): 6548-6562, 2007

Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. Journal of Immunology 124(2): 831-838, 1980

The detection of neutralizing antibody to lymphocytic choriomeningitis virus in mice. Journal of Immunology 102(5): 1128-1135, 1969

Neutralizing serum antibodies of man after infections with the virus of lymphocytic choriomeningitis and the behavior of normal sera in the neutralization test. Archiv für die Gesamte Virusforschung 9: 295-309, 1959

Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains. Journal of Virology 51(1): 34-41, 1984

Microplaque reduction: new assay for neutralizing antibody to lymphocytic choriomeningitis virus. Journal of Infectious Diseases 131(2): 186-188, 1975

Neutralizing antibody response of guinea pigs to lymphocytic choriomeningitis virus. Infection and Immunity 10(3): 516-519, 1974

Detection of the antibody to lymphocytic choriomeningitis virus in sera of laboratory rodents infected with viruses of laboratory and newly isolated strains by ELISA using purified recombinant nucleoprotein. Experimental Animals 57(4): 357-365, 2008

Viral escape from the neutralizing antibody response: The lymphocytic choriomeningitis virus model. Immunogenetics 53(3): 185-189, 2001

Cyto toxic t lymphocyte clones induced by lymphocytic choriomeningitis virus reactivity for lymphocytic choriomeningitis virus strains and major histo compatibility complex antigens. Federation Proceedings 42(5): ABSTRACT 6333, 1983

Fatal central nervous system disease in lymphocytic choriomeningitis virus carrier mice given lymphocytic choriomeningitis virus immune donor spleen cells. Federation Proceedings 30(2): 353, 1971